Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $276B |
| FY2017, ended Dec 31, 2017 | $296B |
| FY2018, ended Dec 31, 2018 | $210B |
| FY2019, ended Dec 31, 2019 | $221B |
| FY2020, ended Dec 31, 2020 | $125B |
| FY2021, ended Dec 31, 2021 | $183B |
| FY2022, ended Dec 31, 2022 | $157B |
| FY2023, ended Dec 31, 2023 | $176B |
| FY2024, ended Dec 31, 2024 | $231B |
| FY2025, ended Dec 31, 2025 | $288B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $240B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $88.3B |
| FY2017, ended Dec 31, 2017 | $88.4B |
| FY2018, ended Dec 31, 2018 | $86.4B |
| FY2019, ended Dec 31, 2019 | $86.8B |
| FY2020, ended Dec 31, 2020 | $74.3B |
| FY2021, ended Dec 31, 2021 | $79.2B |
| FY2022, ended Dec 31, 2022 | $74.4B |
| FY2023, ended Dec 31, 2023 | $82.6B |
| FY2024, ended Dec 31, 2024 | $82.3B |
| FY2025, ended Dec 31, 2025 | $83.7B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $87.2B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income |
|---|---|
| FY2016, ended Dec 31, 2016 | $21.9B |
| FY2017, ended Dec 31, 2017 | $22.2B |
| FY2018, ended Dec 31, 2018 | $22.4B |
| FY2019, ended Dec 31, 2019 | $19.7B |
| FY2020, ended Dec 31, 2020 | $3.38B |
| FY2021, ended Dec 31, 2021 | $22.1B |
| FY2022, ended Dec 31, 2022 | $13.7B |
| FY2023, ended Dec 31, 2023 | $19.1B |
| FY2024, ended Dec 31, 2024 | $19.7B |
| FY2025, ended Dec 31, 2025 | $21.3B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $23.0B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $221B |
| FY2017, ended Dec 31, 2017 | $216B |
| FY2018, ended Dec 31, 2018 | $173B |
| FY2019, ended Dec 31, 2019 | $141B |
| FY2020, ended Dec 31, 2020 | $265B |
| FY2021, ended Dec 31, 2021 | $234B |
| FY2022, ended Dec 31, 2022 | $159B |
| FY2023, ended Dec 31, 2023 | $236B |
| FY2024, ended Dec 31, 2024 | $202B |
| FY2025, ended Dec 31, 2025 | $173B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $179B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $352B |
| FY2017, ended Dec 31, 2017 | $328B |
| FY2018, ended Dec 31, 2018 | $335B |
| FY2019, ended Dec 31, 2019 | $333B |
| FY2020, ended Dec 31, 2020 | $272B |
| FY2021, ended Dec 31, 2021 | $195B |
| FY2022, ended Dec 31, 2022 | $226B |
| FY2023, ended Dec 31, 2023 | $297B |
| FY2024, ended Dec 31, 2024 | $176B |
| FY2025, ended Dec 31, 2025 | $193B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $221B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 40.0% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 5.00B |
| FY2017, ended Dec 31, 2017 | 4.88B |
| FY2018, ended Dec 31, 2018 | 4.55B |
| FY2019, ended Dec 31, 2019 | 4.10B |
| FY2020, ended Dec 31, 2020 | 4.13B |
| FY2021, ended Dec 31, 2021 | 3.81B |
| FY2022, ended Dec 31, 2022 | 3.79B |
| FY2023, ended Dec 31, 2023 | 3.58B |
| FY2024, ended Dec 31, 2024 | 3.29B |
| FY2025, ended Dec 31, 2025 | 3.09B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | 3.00B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash |
|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $8.12B | $779M | $1.42B |
| FY2017, ended Dec 31, 2017 | $9.91B | $849M | $1.21B |
| FY2018, ended Dec 31, 2018 | $20.6B | $1.02B | $632M |
| FY2019, ended Dec 31, 2019 | $24.5B | $1.22B | $380M |
| FY2020, ended Dec 31, 2020 | $3.42B | $622M | $571M |
| FY2021, ended Dec 31, 2021 | $14.5B | $1.00B | — |
| FY2022, ended Dec 31, 2022 | $6.03B | $978M | — |
| FY2023, ended Dec 31, 2023 | $11.9B | $1.12B | — |
| FY2024, ended Dec 31, 2024 | $19.4B | $1.28B | — |
| FY2025, ended Dec 31, 2025 | $17.5B | $1.48B | — |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $14.5B | — | — |
Valuation
At current price- Market Cap
- $248B
- P/E
- 10.8×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 2.8×
- Price / Book
- 1.4×
- EV / EBITDA
- —. (Market cap + debt − cash) / EBITDA (TTM)
Growth
Trailing 12 months- Revenue (TTM)
- $87.2B
- Revenue Growth YoY
- 5.4%
- Revenue CAGR 3Y
- 4.0%
- Revenue CAGR 5Y
- 2.4%
- EPS Growth YoY
- 16.8%
- Net Income Growth YoY
- 9.1%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- —
- Net Margin
- 26.3%
- FCF Margin
- —. Free cash flow / revenue
- Return on Equity
- 12.9%
Earnings
Trailing 12 months- Net Income
- $23.0B
- EPS (diluted)
- $7.09
- EBITDA
- —. Operating income + depreciation & amortization
- Operating Income
- —
Balance Sheet
As of Sep 30, 2026- Cash and cash equivalents
- $179B
- Total Debt
- $221B
- Net Debt
- $41.7B
- Total Assets
- $2.25T
- Total Liabilities
- $2.08T
- Shareholders' Equity
- $176B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $28.9B
- Capital Expenditure
- —
- Free Cash Flow
- —. Operating cash flow − capital expenditure
Dividends and risk
Last 12 months- Dividend Yield
- 2.2%
- Dividend / Share
- $1.85
- Beta (5Y)
- 0.96
Every ratio is calculated from the company’s reported figures.